Latest news
Stay up to date
Receive updates on new technology developments, market and industry trends, special events, Mayo Clinic technologies available for licensing, and more.
Post Bulletin | January 6, 2023
EXCERPT: Mayo Clinic Chief Business Development Officer Jim Rogers spoke to highlight Mayo Clinic’s innovation, citing the launch or involvement with 32 startup companies in 2022 as well as that Mayo inventors have been issued 232 patents.Â
Fierce Biotech | January 3, 2023
Modern Healthcare | January 3, 2023
AP News | December 20, 2022
PR Newswire | December 19, 2022
Fierce Biotech | December 16, 2022
EXCERPT:Â Originally launched in 2021 as a joint venture between nference and Mayo Clinic, Anumana will now work with Pfizer on a multiyear research project.
Business Wire | December 5, 2022
Medical Alley Association | December 1, 2022
Medical Alley Association | December 1, 2022
Healthcare Changemakers Podcast | November 30, 2022
Mayo Clinic News Network | November 29, 2022
Additional Sources: YouTube, Apple Podcasts, Spotify
Fierce Biotech | November 8, 2022
PR Newswire | November 8, 2022
FiercePharma | October 25, 2022
Biz Journals | October 20, 2022
Post Bulletin | October 20, 2022
EXCERPT: “Today’s Investment in Healing Conference brought together key collaborators who are playing a pivotal role in the creation of a dynamic platform ecosystem,” wrote Mayo Clinic President and CEO Dr. Gianrico Farrugia.
Mayo Clinic News Network | October 12, 2022
Healthcare IT News | October 3, 2022
MobiHealthNews | September 21, 2022
BioSpace | September 20, 2022
EXCERPT:Â Â MoatBio holds an exclusive patent license from Mayo Clinic for the novel second generation single-cycle adenovirus vaccine platform (SC-AdVax) to develop intranasal and oral vaccines that can elicit and boost both mucosal and systemic immunity for the treatment of infectious diseases, like COVID-19.Â
Twin Cities Business | September 1, 2022
EXCERPT:Â Mayo Clinic Ventures chair Andrew Danielsen estimated that the accelerator will give birth to about one to three new companies a year.
Mayo Clinic, Hibiscus BioVentures and Innoforce announce Mayflower cell and gene therapy accelerator
Mayo Clinic News Network | August 31, 2022